Page 3 - Emcure
Emcure Pharma to launch oral Covid drug for emergency use in India
Emcure Pharmaceuticals Ltd announced that it has received Emergency Use Authorisation approval for launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19.
 "Emcure Pharma to launch oral Covid drug for emergency use in India")
Gennova's mRNA-based Covid vaccine gets nod for Phase 2/3 clinical trials
Gennova's mRNA-based Covid vaccine development programme was partly funded by the DBT under Ind CEPI in June 2020
 "Gennova's mRNA-based Covid vaccine gets nod for Phase 2/3 clinical trials")
Emcure strengthens board by including 4 new independent directors
Emcure Pharmaceuticals on Tuesday said it has strengthened its board with the inclusion of four new independent directors, including former Foreign Secretary Vijay Keshav Gokhale. The others who have joined the company's board are Shailesh Ayyangar, Hitesh Jain and Vidya Yeravdekar. Earlier this year, Berjis Desai had taken over as the chairman of Emcure Board. The company has had a long-standing tradition of appointing a Chairman from amongst its independent directors since 1997. "We are delighted to have highly accomplished industry stalwarts as part of our board. New members' combined experience and wider perspective from their respective fields, will play an instrumental role in strengthening our strategic operations to grow in domestic and international markets," Emcure Pharmaceuticals Managing Director & CEO Satish Mehta said in a statement. The drug firm aims to further augment its strengths as one of the fastest growing pharmaceutical companies in India with a global reach
 "Emcure strengthens board by including 4 new independent directors")
Emcure launches generic breast cancer drug 40% cheaper than innovator's
Emcure plans to capture 25 per cent of the market for the drug as well as expand the market through this cheaper alternative to the innovator drug
 "Emcure launches generic breast cancer drug 40% cheaper than innovator's")
2 ex-executives of Emcure's US arm accused of price fixing
Jeffrey Glazer and Jason Malek are also charged with rigging bids and price collusion
US FDA warns Emcure Pharma, cites repeated data fudging at plant
Regulator writes to the firm on 'significant violations' of manufacturing practices at the company' s Pune plant
 "US FDA warns Emcure Pharma, cites repeated data fudging at plant")